Percutaneous Intervention and Anticoagulation Outcome of Urgent and Elective Percutaneous Coronary Interventions After Pharmacologic Reperfusion With Tenecteplase Combined With Unfractionated Heparin, Enoxaparin, or Abciximab

نویسندگان

  • Christophe L. Dubois
  • Paolo M. Fioretti
  • José L. López-Sendón
  • Freek W. Verheugt
چکیده

Christophe L. Dubois, MD,* Ann Belmans, MSC,*† Christopher B. Granger, MD, FACC,‡ Paul W. Armstrong, MD, FACC,§ Lars Wallentin, MD, FACC, Paolo M. Fioretti, MD, FACC,¶ José L. López-Sendón, MD, FACC,# Freek W. Verheugt, MD, FACC,** Jürgen Meyer, MD, FACC,†† Frans Van de Werf, MD, FACC,* on behalf of the ASSENT-3 Investigators Leuven, Belgium; Durham, North Carolina; Edmonton, Canada; Uppsala, Sweden; Udine, Italy; Madrid, Spain; Nijmegen, The Netherlands; and Mainz, Germany

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Tissue Doppler imaging: diagnostic and prognostic value.

1. Cannon CP, Gibson CM, Lambrew CT, et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941–7. 2. Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771–5. 3. Brodie BR, ...

متن کامل

[Use of a combination of enoxaparin or unfractionated heparin and abciximab during percutaneous coronary interventions: a randomized pilot study].

OBJECTIVES The cumulative experience gleaned from the NICE trials suggests that adjunctive enoxaparin therapy for percutaneous transluminal coronary angioplasty (PTCA), with or without concomitant abciximab therapy, is both safe and effective. However, no randomized studies have been conducted to compare the two strategies. The aim of this study was to evaluate the safety of combined enoxaparin...

متن کامل

[Commentary to the article: Montalescot G, White HD, Gallo R, et al. STEEPLE Investigators. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention].

BACKGROUND Despite its limitations, unfractionated heparin has been the standard anticoagulant used during percutaneous coronary intervention (PCI). Several small studies have suggested that intravenous enoxaparin may be a safe and effective alternative. Our primary aim was to assess the safety of enoxaparin as compared with that of unfractionated heparin in elective PCI. METHODS In this pros...

متن کامل

Direct stenting: safe with advantages for the patient and for the doctor (less fluoroscopy and procedural time).

pattern — no improvement in early reperfusion, but there was a reduced rate of recurrent myocardial infarction. In streptokinase-treated patients, TIMI grade 3 flow at 20–28 h later tended to be higher in patients treated with dalteparin (68% vs 51% for unfractionated heparin, P=0·10), and the number of ischaemic episodes on continuous ECG monitoring was lower (16% vs 38%, P=0·04) with similar ...

متن کامل

Distinct yet complementary mechanisms of heparin and glycoprotein IIb/IIIa inhibitors on platelet activation and aggregation: implications for restenosis during percutaneous coronary intervention.

OBJECTIVE To study the effect of unfractionated heparin (UFH) versus low molecular weight heparin (LMWH) in combination with glycoprotein (Gp) IIb/IIIa blockers on platelet activation and aggregation. METHODS Washed platelets were stimulated with thrombin in the presence or absence of UFH (monoparin), LMWH (enoxaparin), and a Gp IIb/IIIa blocker (abciximab, eptifibatide, or tirofiban). RESU...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2016